Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations by Rennert Gad, Bisland-Naggan Shantih, Barnett-Griness Ofra, Bar-Joseph Naomi, Zhang Shiyu, Rennert Hedy S, Narod Steven A in The New England journal of medicine (2007).

[PMID: 17625123] PubMed


Some features of breast cancer in women with a BRCA1 mutation suggest that hereditary breast cancer has a poor outcome. We conducted a national population-based study of Israeli women to determine the influence, if any, of a BRCA1 or a BRCA2 mutation on the prognosis in breast cancer.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.